Monday Lunch Live

14 August 2023

Take a deep dive into the opportunities and limitations of new trial methodologies and their implementation - specifically, registry trials and teletrials. 

Both of these trial types show a lot of promise, with early data pointing to their potential for increasing trial recruitment and participation for consumers, especially in remote or rural areas. They also reduce administrative burden on trial units and allow clinicians and researchers to learn valuable lessons from as many patients as possible. However, there's more to be done to see them more widely adopted in clinical settings.

Professor Peter Gibbs and clinical trial experts look at how registry trials and teletrials are placed in the context of the cancer clinical trial landscape, share important case studies, and discuss how to forge a path towards greater clinical uptake of these trials in the future.

The webinar concludes with a panel discussion.